clinical pharmacy pathway

Overview

Training designed to educate pharmacists on how to best implement interprofessional collaboration within clinics and with local providers to better care for patients with chronic conditions. This year, focus will be on many of the "soft" skills that are needed to effectively work with chronic conditions, with a few clinical session thrown in as well. Learners may take one or all of these courses but completing the full series (6 classes for 6 hours of CE) will earn them the 2025 Clinical Pharmacy Pathway Certificate from Kansas Pharmacists Association. Choose the date/time option for each module that best fits your schedule - each course will be offered once as a live webinar, then available on demand as well.

• Chronic Kidney Disease
• Tuesday, April 29th, 12-1pm
• Dr Cassie Shields, Salina Family Healthcare
• Course description coming soon!
• No Fluff, Just Facts: GLP-1 Edition
• Tuesday, May 6th, 1-2pm
• Dr Michelle Wessling, PharmD, BCACP - LMH Health
• This presentation will be focused on real world use of GLP1 RAs and clinical pearls used in daily management of patients on GLP1 RAs
• Less Finger-Pricking, More Living: The Magic of CGMs and Insulin Pumps
• Saturday, May 10th 8:30-9:30am
• Dr Madison Auten, PharmD, BCACP - St Luke's Health System
• This presentation is going to help give a general idea of what CGMs and insulin pumps are available, how to read and interpret a CGM report as well as educate patients on the use of these devices for diabetes management. We will also discuss the role CGMs play in patients who may be prediabetic and what information is available to them to prevent diabetes. A brief overview of insurance coverage and billing for these services will also be provided.
• Where do you see yourself in 10 years? Non-statin Therapies for LCL lowering and ASCVD Risk Reduction Optimization
• Wednesday, May 14th - 12-1pm
• Dr Emily Prohaska, PharmD, BCACP, FAPhA - LMH Health
• This program will summarize key treatment recommendations from the 2022 ACC Expert Consensus Decision Pathway on the Role of Nonstatin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk. Patient cases will be included to integrate recommendations into current practice.
• Guideline Directed Medical Therapy for Heart Failure
• Saturday, May 17th - 8:30-9:30am
• Dr Frank Fanizza, PharmD, BCACP - VA St Louis Health Care System
• This program will focus on reviewing current recommendations for guideline-directed medication therapies (GDMT) for the different forms of heart failure. In addition to reviewing the latest guideline recommendations, the program will also evaluate and discuss  recent landmark clinical trials to help provide the audience with the rationale for guideline recommendations and also to highlight therapies that may be of benefit for patients with certain types of heart failure but have not been included in the guidelines to date.
• Three More Minutes: Extended Patient Counseling to Improve Self-Management Strategies
• Tuesday, May 20th - 12-1pm
• Dr Abigail Petrulis, PharmD, MS, BCPS - Indian Health Services - Haskell
• This program will provide strategies for the community, ambulatory and inpatient pharmacists to improve their communication and patient education. This can be done in the shortest patient encounters, taking only a few minutes longer than a standard session, or longer if the opportunity allows.